
Healthup S.A., operating under the brand AioCare, offers a portable spirometry system designed for home use to monitor and manage lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Their product includes a class IIa medical device spirometer paired with an intuitive mobile app that allows patients to perform spirometry tests at home, with real-time data accessible to physicians via the AioCare Panel. This system enables personalized treatment adjustments, early detection of health deterioration, and better disease management, reducing exacerbations. The company operates on a subscription-based model with device sales and offers plans with varying features including digital diaries, asthma action plans, and encrypted communication with healthcare providers. AioCare is certified by TUV Nord and compliant with GDPR, with a growing presence in primary healthcare centers and positive user testimonials, positioning it as an innovative player in digital respiratory health monitoring.

Healthup S.A., operating under the brand AioCare, offers a portable spirometry system designed for home use to monitor and manage lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Their product includes a class IIa medical device spirometer paired with an intuitive mobile app that allows patients to perform spirometry tests at home, with real-time data accessible to physicians via the AioCare Panel. This system enables personalized treatment adjustments, early detection of health deterioration, and better disease management, reducing exacerbations. The company operates on a subscription-based model with device sales and offers plans with varying features including digital diaries, asthma action plans, and encrypted communication with healthcare providers. AioCare is certified by TUV Nord and compliant with GDPR, with a growing presence in primary healthcare centers and positive user testimonials, positioning it as an innovative player in digital respiratory health monitoring.
Product: Portable CE-marked spirometer + mobile app + clinician panel for home monitoring of asthma and COPD
Business model: Device sales plus subscription-based service plans
Founding location & year: Warsaw, Poland; founded 2015
Regulatory/quality: Medical Device Class IIa, CE marking, ISO 13485 certified
Funding: Seed round closed Feb 3, 2016; investor listed as Joint Polish Investment Fund
Digital respiratory health monitoring and chronic respiratory disease management (asthma, COPD).
2015
Digital health / Medical devices
One recorded funding round in public profiles; total amount in some databases is obfuscated.
“Joint Polish Investment Fund”